Tenax Therapeutics, Inc. Made Headway
Tue, Feb 06, 2024 at 07:16 PM
Tenax Therapeutics, Inc. (TENX:NASDAQ) jumped higher at $11.45, representing a gain of 31%. On Tue, Feb 06, 2024, TENX:NASDAQ hit a New 2-Week Intraday High of $21.46. The stock got featured on our News Catalysts scanner on Tue, Feb 06, 2024 at 10:42 AM in the 'PRIVATE PLACEMENT' category. From Tue, Jan 23, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Feb 06, 2024 at $21.46 with a volume of 9M+.
About Tenax Therapeutics, Inc. (TENX:NASDAQ)
Tenax Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing & commercializing pharmaceutical products for critical care patients and its products include Levosimendan & Oxycyte.
Top 10 Gainers:
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 136.94%
- USD Partners LP (USDP:NYSE), 93.39%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 92.4%
- ADDvantage Technologies Group, Inc. (AEY:NASDAQ), 77.14%
- Equillium, Inc. (EQ:NASDAQ), 52.78%
- Zenvia Inc. (ZENV:NASDAQ), 52.14%
- Meiwu Technology Company Limited (WNW:NASDAQ), 45%
- Immunome Inc. (IMNM:NASDAQ), 36.91%
- Tellurian Inc. (TELL:NYSEMKT), 32.57%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 31.01%